Skip to main content Skip to main navigation menu Skip to site footer
Scientific Electronic Archives
Health Science
DOI: 10.36560/18120252010
Submitted: 2024-09-20
Published: 2024-12-16

Preventive cervical cancer screening exam and its incidence before, during and after the pandemic

Universidade Estadual de Montes Claros
Faculdade Atenas Sete Lagoas
Universidade Federal de Mato Grosso
Pathology,Epidemiology,Diagnosis,How prevention is done ou How prevention is carried out,Post-pandemic treatment.

Abstract

Cervical cancer remains a leading cause of female mortality and is largely preventable through cervical cytology screening, known as the Pap test. This study evaluates the impact of the COVID-19 pandemic on cervical cancer screening rates in Brazil, using DATASUS data from 2018 to 2024. The results reveal a dramatic 70% reduction in screenings during the pandemic's peak in 2020, attributed to health restrictions and social distancing measures. Although there has been partial recovery in subsequent years, screening rates have not returned to pre-pandemic levels. The ongoing decline in screenings underscores the urgent need for enhanced prevention strategies and sustained public health campaigns to encourage continuous screening. Early detection of cervical cancer is crucial for effective disease management, highlighting the importance of addressing the lasting impact of the pandemic on women's health.

References

  1. ARAÚJO, Karina Sebastiana Macedo et al. RASTREIO E DIAGNÓSTICO DE LESOES PRECURSORAS DO CANCER DE COLO DO ÚTERO EM MULHERES EM IDADE REPRODUTIVA NO HOSPITAL DR. RAFAEL ZAMORA ARÉVALO. Revista Multidisciplinar em Saúde, v. 1, n. 3, p. 69-69, 2020.
  2. BARROS, Ângela Maria Melo Sá et al. Perfil epidemiológico dos casos de câncer do colo uterino no estado de Sergipe. Revista Eletrônica Acervo Saúde, v. 15, n. 4, p. e10043-e10043, 2022.
  3. CERQUEIRA, Raisa Santos et al. Controle do câncer do colo do útero na atenção primária à saúde em países sul-americanos: revisão sistemática. Revista Panamericana de Salud Pública, v. 46, p. e107, 2023.
  4. DE MENDONÇA, Emanuela Cavalcante et al. Tratamento do câncer do colo do útero no contexto do Sistema Único de Saúde (SUS): revisão sistemática. Research, Society and Development, v. 11, n. 16, p. e314111638421-e314111638421, 2022.
  5. DE SOUZA, Daniele Andrade; DE OLIVEIRA COSTA, Marli. O papel do enfermeiro na prevenção do câncer no colo de útero. Research, Society and Development, v. 10, n. 13, p. e137101321040-e137101321040, 2021.
  6. MILITÃO, Bruno Vítor Peixoto et al. Repercussões da pandemia de Sars-Cov-2 na realização do exame de Papanicolaou: um estudo epidemiológico. Revista Eletrônica Acervo Saúde, v. 13, n. 9, p. e8869-e8869, 2021.
  7. MOURA, Erly Catarina et al. Covid-19: evolução temporal e imunização nas três ondas epidemiológicas, Brasil, 2020–2022. Revista de Saúde Pública, v. 56, p. 105, 2022.
  8. SATURNINO, Aline de Fátima Rodrigues et al. O papanicolau como exame de rastreio do câncer de colo de útero e suas implicações na pandemia. Scientific Electronic Archives, v. 16, n. 9, 2023.
  9. Parâmetros técnicos para o rastreamento do câncer do colo do útero / Instituto Nacional de Câncer José Alencar Gomes da Silva; Maria Beatriz Kneipp Dias; Caroline Madalena Ribeiro (organizadores). - Rio de Janeiro: Inca, 2019.
  10. VALÉRIO, Marcela Pugas et al. Câncer de colo de útero: do diagnóstico ao tratamento/Cervical Cancer: From Diagnosis to Treatment. Brazilian Journal of Development, v. 8, n. 3, p. 20235-20241, 2022.

How to Cite

Barbosa, L. N., Tavares, A. C. T., & Paula, M. G. de. (2024). Preventive cervical cancer screening exam and its incidence before, during and after the pandemic. Scientific Electronic Archives, 18(1). https://doi.org/10.36560/18120252010